China’s Dezhan Health said it launched a hemp cosmetics series and a hemp-based drink on the domestic market on a trial basis, and announced a series of asset acquisitions in the big health industry involving industrial hemp, disinfectant, peptide, vaccines and other industries. Also, Deyi Pharmaceutical, a Dezhan subsidiary, said it is advancing research in the chemical synthesis of cannabinoids for medical applications.
Posted By: HempToday® December 16, 2020
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.